Search research articles
Contact Us
Filters
Showing results (251-260 of 469) with videos related to
Page
of 47
Sort By:
The American Journal of Surgical Pathology
|
March 17, 2025
SMARCB1-deficient Sinonasal Carcinoma: Expanding the Pathologic Spectrum With a Series of 32 Cases
Neha Mittal, Saurabh Nagar, Asawari Patil, et al.
JCO Global Oncology
|
January 8, 2025
Prevalence of <i>EGFR</i> Mutations in Patients With Resected Stage I to III Nonsquamous Non-Small Cell Lung Cancer: Results of India Cohort
Ullas Batra, Kumar Prabhash, Vanita Noronha, et al.
The Journal of Liquid Biopsy
|
June 12, 2025
Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience
Prerana Jha, Rohit Mishra, Asim Joshi, et al.
Oral Oncology
|
January 13, 2015
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck
Vijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
South Asian Journal of Cancer
|
February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burden
Amit Joshi, Vijay M Patil, Vanita Noronha, et al.
Cancer Medicine
|
March 28, 2022
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin
Nandini S Menon, Vanita Noronha, Vijay Maruti Patil, et al.
Indian Journal of Surgical Oncology
|
January 23, 2023
Anaplastic Cancer: Our Experience
Aditya Pavan Kumar Kanteti, Joy Ghose, Vijay Maruti Patil, et al.
Oral Oncology
|
May 31, 2022
Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients
Vijay M Patil, Manali Kolkur, Sravan Kumar Chinthala, et al.
Oral Oncology
|
April 7, 2016
Technically unresectable recurrent oral cancers: Is NACT the answer?
Vijay M Patil, Amit Joshi, Vanita Noronha, et al.
Ecancermedicalscience
|
December 12, 2017
Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases
Jai Prakash Agarwal, Santam Chakraborty, Sarbani Ghosh Laskar, et al.
Page
of 47
Search research articles
Search
Showing results (251-260 of 469) with videos related to
Sort By:
Page
of 47
The American Journal of Surgical Pathology
|
March 17, 2025
SMARCB1-deficient Sinonasal Carcinoma: Expanding the Pathologic Spectrum With a Series of 32 Cases
Neha Mittal, Saurabh Nagar, Asawari Patil, et al.
JCO Global Oncology
|
January 8, 2025
Prevalence of <i>EGFR</i> Mutations in Patients With Resected Stage I to III Nonsquamous Non-Small Cell Lung Cancer: Results of India Cohort
Ullas Batra, Kumar Prabhash, Vanita Noronha, et al.
The Journal of Liquid Biopsy
|
June 12, 2025
Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience
Prerana Jha, Rohit Mishra, Asim Joshi, et al.
Oral Oncology
|
January 13, 2015
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck
Vijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
South Asian Journal of Cancer
|
February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burden
Amit Joshi, Vijay M Patil, Vanita Noronha, et al.
Cancer Medicine
|
March 28, 2022
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin
Nandini S Menon, Vanita Noronha, Vijay Maruti Patil, et al.
Indian Journal of Surgical Oncology
|
January 23, 2023
Anaplastic Cancer: Our Experience
Aditya Pavan Kumar Kanteti, Joy Ghose, Vijay Maruti Patil, et al.
Oral Oncology
|
May 31, 2022
Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients
Vijay M Patil, Manali Kolkur, Sravan Kumar Chinthala, et al.
Oral Oncology
|
April 7, 2016
Technically unresectable recurrent oral cancers: Is NACT the answer?
Vijay M Patil, Amit Joshi, Vanita Noronha, et al.
Ecancermedicalscience
|
December 12, 2017
Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases
Jai Prakash Agarwal, Santam Chakraborty, Sarbani Ghosh Laskar, et al.
Page
of 47